bioRxivBiophysics
Investigating the physical effects in bacterial therapies for avascular tumors
Abstract
Tumor-targeting bacteria elicit anticancer effects by infiltrating hypoxic regions, releasing toxic agents and inducing immune responses. Although current research has largely focused on the influence of chemical and immunological aspects on the mechanisms of bacterial therapy, the impact of physical effects is still elusive. Here, we propose a mathematical model for the anti-tumor activity of bacteria in avascular tumors that takes into account the relevant chemo-mechanical effects. We consider a time-dependent administration of bacteria and analyze the impact of bacterial chemotaxis and killing rate. We show that active bacterial migration towards tumor hypoxic regions provides optimal infiltration and that high killing rates combined with high chemotactic values provide the smallest tumor volumes at the end of the treatment. We highlight the emergence of steady states in which a small population of bacteria is able to constrain tumor growth. Finally, we show that bacteria treatment works best in the case of tumors with high cellular proliferation and low oxygen consumption.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tumor Stroma Content Regulates Penetration and Efficacy of Tumor-targeting Bacteria
- Programming the lifestyles of engineered bacteria for cancer therapy
Shengwei Fu, Rongrong Zhang, … Fan Jin·National Science ReviewPeer-reviewed·Feb 11, 2023
- Veillonella parvula: a strictly anaerobic bacterium with high efficacy for safe and specific tumor targeting and colonization
A. Kefayat, F. Ghahremani, S. Rostami·bioRxiv·May 10, 2021
- Multiscale modeling of tumor adaption and invasion following anti-angiogenic therapy
Colin G. Cess, Stacey D. Finley·Computational and Systems OncologyPeer-reviewed·Feb 21, 2022
- Hypoxia in cancer chemo- and immunotherapy: foe or friend?
Noemi Vitos, Shannon Chen, … Katarzyna Anna Rejniak·bioRxiv·Aug 4, 2019
- Expanding the therapeutic window of bacteria for cancer therapy
Jongwon Im, Meghna Komaranchath, … Tal Danino·bioRxiv·Oct 29, 2026